Dec 30, 2013 | Digital Pathology, Instruments & Equipment, Laboratory Instruments & Laboratory Equipment, Laboratory Management and Operations, Laboratory News, Laboratory Operations, Laboratory Pathology, Management & Operations
New insights about personal genomes will give pathologists and clinical laboratory scientists different ways to use genetic tests in the screening, diagnosis, and treatment of disease
Here is a human genome curve ball for pathologists and clinical laboratory scientists engaged in genetic testing in their medical laboratories. New research indicates that a larger number of humans than was once believed may have more than one genome. This has implications for many medical and health issues.
Until recently, scientists assumed that, as a rule, each individual had a unique genome. Conditions such as mosaicism and chimerism were considered a rarity.
Greater Incidence of Multiple Genomes in a Single Individual (more…)
Nov 19, 2012 | Compliance, Legal, and Malpractice, Laboratory Instruments & Laboratory Equipment, Laboratory Management and Operations, Laboratory News, Laboratory Operations, Laboratory Pathology, Management & Operations
Medical laboratory professionals will be surprised to learn that some experts claim American healthcare will not see a return on investment from use of EHR systems
It is the popular wisdom today that universal adoption of electronic health record (EHR) systems will lead to significant improvements in patient outcomes, while also delivering substantial cost savings to the American health system.
However, this trend also requires clinical laboratories to spend substantial amounts of money to provide electronic interfaces between their laboratory information systems (LIS) and EHR systems of their client physicians.
Until recently, very little criticism of these federal EHR subsidies has appeared in the media. However, some experts now assert that tens of billions of dollars hospitals and physicians are spending to implement EHRs and integrate their information systems will never be recouped by downstream savings. (more…)
Nov 7, 2011 | Instruments & Equipment, Laboratory Instruments & Laboratory Equipment, Laboratory Pathology
Enhanced functionality of software promises a giant boost in tissue analysis
Surgical pathologists may have an exciting new tool for identifying and classifying cancer-related cells. Medical researchers at Duke University are demonstrating that “active learning” software developed for finding and recognizing undersea mines can help pathologists identify and classify cancer-related cells.
The Duke research team embedded the active learning software into an existing software toolkit, called FARSIGHT, which is a collection of software modules. FARSIGHT was designed to rapidly analyze images of human tissue collected from laser-scanning microscopes, an article in University of Houston Engineering News explained. It can be scripted to accomplish a variety of automated image analysis tasks, from analyzing brain tissue to studying the effectiveness of medications.
“The results are spectacular,” said Lawrence Carin, Ph.D., Professor, Electrical Engineering Department at Duke, stated in an Office of Naval Research press release. “This could be a game-changer for medical research.”
(more…)
Oct 28, 2011 | Coding, Billing, and Collections, Laboratory News, Laboratory Pathology
Data represents $1 trillion in spending since 2000 and contains clinical laboratory and pathology data
In what may turn out to be a positive development for clinical laboratories and pathology group practices, four of the nation’s five biggest health insurance companies will collaborate and put their medical claims data for billions of transactions into a single data base. Researchers say this database will give them an unprecedented ability to assess utilization trends and the clinical care delivered to patients covered by private health insurance.
The four health insurance companies that will provide data are:
The data provided by each of these health insurers will be submitted to the newly-created Health Care Cost Institute (HCCI). This data will consist of more than five billion medical claims dating back to 2000. These claims represent more than $1 trillion in spending. The health insurers are also providing the financing required to launch HCCI. (more…)
